Avadel Pharmaceuticals PLC (AD - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AVDL Nasdaq 2834 https://www.avadel.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Avadel Pharmaceuticals PLC (AD

Jazz (JAZZ) Acquires Cavion, Adds Movement Disorder Candidate - Aug 13th, 2019 9:12 am
Avadel Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Company Update - Aug 9th, 2019 5:00 am
Avadel Pharmaceuticals Receives New PDUFA Date for AV001 of December 15, 2019 - Aug 8th, 2019 2:05 pm
Avadel Pharmaceuticals Further Strengthens Clinical and Medical Team - Aug 1st, 2019 5:00 am
Avadel Pharmaceuticals to Report Second Quarter 2019 Financial Results - Jul 29th, 2019 5:00 am
Do Directors Own Avadel Pharmaceuticals plc (NASDAQ:AVDL) Shares? - Jul 17th, 2019 10:39 am
Jazz (JAZZ) Acquires Early-Stage Precision Oncology Asset - Jul 10th, 2019 8:22 am
Jazz's (JAZZ) New Sleep Drug Sunosi Gets Schedule IV Status - Jun 18th, 2019 7:45 am
Avadel to Present New Data on Once-Nightly Sodium Oxybate at SLEEP 2019 Conference - Jun 4th, 2019 5:00 am
Avadel Pharmaceuticals Appoints Gregory J. Divis Chief Executive Officer - Jun 3rd, 2019 5:06 am
Avadel Pharmaceuticals Announces FDA Acceptance of New Drug Application for AV001 - May 22nd, 2019 6:00 am
Introducing Avadel Pharmaceuticals (NASDAQ:AVDL), The Stock That Tanked 82% - May 8th, 2019 8:16 am
Avadel: 1Q Earnings Snapshot - May 8th, 2019 5:53 am
Avadel Pharmaceuticals Reports First Quarter 2019 Financial Results - May 8th, 2019 5:00 am
Avadel Pharmaceuticals Plc to Host Earnings Call - May 8th, 2019 4:30 am
Avadel Pharmaceuticals to Report First Quarter 2019 Financial Results - Apr 29th, 2019 2:30 pm
Avadel Pharmaceuticals Announces Appointment of Jordan Dubow, M.D., as Chief Medical Officer - Apr 29th, 2019 6:00 am
Jazz's Xyrem Follow-On Drug Succeeds in Phase III Study - Mar 27th, 2019 2:30 pm
Jazz Pharmaceuticals' Sleep Drug NDA Awaits FDA Decision - Mar 20th, 2019 9:14 am